Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.26 | N/A |
| PEG Ratio (TTM) | 0.12 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 0.89 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 18.74 | N/A |
| Price to 5YR AVG FCF Ratio | 2.77 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.92% | N/A |
| ROE (TTM) | 7.35% | N/A |
| Net Profit Margin (TTM) | 26.57% | N/A |
| ROIC 5YR AVG | 9.78% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.31% | 20.54% | 19.22% |
| Revenue | 1.11% | 14.98% | 9.02% |
| Net Income | 4.40% | 31.17% | 26.50% |
| Cash Flow | 108.47% | 26.03% | 5.45% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 55.05 | N/A |
| Quick Ratio (TTM) | 55.05 | N/A |
| D/E Ratio (TTM) | 0.56 | N/A |
| Interest Coverage (TTM) | 8.05 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.04 | N/A |
| LTL to 5YR AVG FCF | 8.71 | N/A |
| Shares Outstanding Growth 5YR AVG | 7.77% | N/A |